Core Scientific, Inc. CORZ

17.34 (0.79) (4.36%) as of 25 Sep
Market cap
$5.9B
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month

Insider Decisions

Total buys 0.55
Total sells 5.62
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — 1 — — — 1 — — — — 2 1
Sell — — — — — — 5 4 5 4 5 3
Insider Ownership 5.74%

Capital & Financial Ratios

Market Cap 5,890.00
Revenue 440.31
Net Income (1,430.57)
Free Cash Flow (1,194.74)
Net Debt 2,362.49
Current Ratio 0.89
Debt/Equity (1.78)
P/E ratio 0.00
P/S ratio 12.83
P/B ratio 0.00
Past 5Y EPS Growth (1,117.00%)
This Y EPS Growth (409.01%)
Next Y EPS Growth 106.25%
Next 5Y EPS Growth 41.40%
in millions of $

Dividends

Payout Ratio —
Annual Dividend Rate —
Annual Dividend Yield —

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 70 837 311 1,935
Receivables 1 — — —
Inventory — — — —
Other 2 67 584 508
97 904 896 2,444
2023 2024 2025 Q'26
Payables 155 19 126 112
ST’ Debt — — — —
Other — 32 16 1,829
488 135 781 2,738
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — 39.53% (20.72%)
Cash Flow — 0.00% 10.69%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue

Mar Jun Sep Dec Year
’26 115 164 — — —
’25 80 79 81 80 319
’24 179 141 95 95 511
’23 121 127 113 142 502
’22 193 164 163 121 640
’21 54 75 113 302 544
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 250 (19) — — —
’25 (45) 34 136 153 278
’24 22 1 6 14 43
’23 20 18 5 22 65
’22 (4) 145 (52) 116 205
’21 15 (137) (45) 110 (57)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (137) (815) — — —
’25 (129) (86) (123) (120) (457)
’24 (10) (2) (26) (15) (52)
’23 18 17 3 10 48
’22 (273) (31) (57) (24) (386)
’21 5 (165) (122) 167 (115)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (1.06) (3.32) — — —
’25 1.25 (2.95) (0.46) 0.42 (0.88)
’24 0.78 (4.51) (1.17) (0.60) (4.39)
’23 0.00 (0.02) (0.11) (0.51) (0.65)
’22 (1.52) (2.49) (1.23) (1.06) (6.30)
’21 0.04 (0.02) (0.07) 0.26 0.20
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1.2
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — — — — — 2.61 6.20

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — — — — — 18.63 23.63
High Price
— — — — — — 235 286 325 325
Employees
— — — — 0 0 3 2 2 1
Revenue/Emp
— — — — 60 544 640 502 511 319
Revenue
— — — — 15.57% 43.87% 1.31% 24.57% 23.71% 11.88%
Gross Margin
— — — — (12) 63 (2,163) (246) (1,437) (288)
EBT
— — — — (20.24%) 11.58% (337.87%) (48.93%) (281.40%) (90.29%)
EBT Margin
— — — — (12) 47 (2,146) (246) (1,438) (289)
Net Income
— — — — 11 35 1,883 97 124 86
Depreciation
— — — — 0.38 2.63 1.88 1.32 2.00 1.00
Revenue/Sh
— — — — (0.08) 0.23 (6.30) (0.65) (4.39) (0.88)
Earnings/Sh
— — — — (0.15) (0.27) 0.60 0.17 0.17 0.87
Cash Flow/Sh
— — — — (0.01) (0.28) (1.73) (0.04) (0.37) (2.31)
Capex/Sh
— — — — (0.16) (0.56) (1.13) 0.13 (0.20) (1.44)
Free CF/Sh
— — — — 0.00 6.47 (1.20) (1.57) (3.69) (3.03)
Book Value/Sh
— — — — 158 207 341 380 256 318
Shares
— — — — 0.00 0.00 0.00 0.00 0.00 0.00
PE Ratio
— — — — 2.60 2.60 2.60 2.60 7.04 14.52
PS Ratio
— — — — 0.00 0.00 0.00 0.00 0.00 0.00
PB Ratio
— — — — 3.90 3.90 3.90 3.90 7.50 16.86
EV/Sales
— — — — 40.67 40.67 40.67 40.67 (73.26) (11.76)
EV/FCF
— — — — (24) (57) 205 65 43 278
Op' Cash Flow
— — — — (2) (59) (591) (17) (95) (736)
Capex
— — — — (25) (115) (386) 48 (52) (457)
FCF
— — — — — 436 (102) (391) 769 114
Working Cap'
— — — — — 714 — 720 1,074 1,060
Total Debt
— — — — — 583 (52) 650 237 749
Net Debt
— — — — 0 1,341 (409) (597) (943) (963)
Sh' Equity
— — — — 0.00% 3.88% (132.22%) (32.44%) (131.43%) (15.10%)
ROA
— — — — 0.00% 4.27% 0.00% 10.53% 0.00% 0.00%
ROIC
— — — — 0.00% 0.00% (460.65%) 48.99% 186.74% 30.29%
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Core Scientific, Inc. peers in Software Infrastructure

Company Market cap P/E Compare
BLSH Bullish $6.0B 0.0× Compare
DOX Amdocs Limited $6.2B 13.7× Compare
VRNS Varonis Systems, Inc. $5.5B 0.0× Compare
WEX WEX Inc. $6.3B 17.5× Compare
Company Market cap P/E Compare
QLYS Qualys, Inc. $6.3B 29.7× Compare
PATH UiPath, Inc. $6.6B 18.6× Compare
BB BlackBerry Limited $5.2B 86.9× Compare
ACIW ACI Worldwide, Inc. $5.0B 22.5× Compare

All 173 Software Infrastructure stocks →

Core Scientific, Inc. (CORZ) key facts

  • Core Scientific, Inc. (CORZ) is a Software Infrastructure company in the Technology sector, listed on Nasdaq.
  • Core Scientific, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $319.0 million, down 37.5% from fiscal 2024.
  • As of September 25, 2026, CORZ traded at $17.34, a market capitalization of $5.9 billion.
  • Return on equity was 30.3% and debt-to-equity -1.78.

Source: company filings (standardised) and stockrow calculations.

Core Scientific, Inc. (CORZ) Latest News

News by impact score

Fine-tune

25 Sep

4

Core Scientific named Jay Elms Chief Commercial Officer to lead sales and commercial execution across hosting and infrastructure services. Elms, with data-center experience from CyrusOne and NTT, will pursue hyperscale and wholesale clients as the company shifts from Bitcoin mining to high-performance computing. The role targets converting contracted power and reserved capacity into AI/hyperscale revenue, including multi-year deals beyond CoreWeave and AMD, while pushing expansion of roughly 1.9 GW of optioned capacity. Risks cited include customer concentration, cash runway, and potential delays in new capacity. The move aligns with its AI infrastructure strategy but leaves execution and funding risks in place. Adds experienced commercial leadership to execute AI/HPC contracts and diversify revenue, potentially shifting growth trajectory.

11 Sep

3

Core Scientific’s Batch Zero classifications feature a surprise base load candidate. Batch Zero classifications with a surprise base load candidate may affect Core Scientific energy operations.

3

APLD considers developing AI data centers at power-advantaged sites, creating potential competition for Core Scientific (CORZ) in high-efficiency infrastructure for AI workloads. APLD's AI data center plans at power sites introduce new competition that may affect CORZ positioning in the sector.

10 Sep

4

Core Scientific secures conditional ERCOT approvals covering up to 1,402 MW of power capacity. Approvals grant major power capacity critical for expanding Bitcoin mining operations and revenue growth.

4

Core Scientific receives conditional ERCOT approvals for Texas power capacity. Conditional ERCOT approvals directly expand Core Scientific's operational power capacity in Texas and support mining site growth.

30 Aug

3

Billionaire hedge fund manager invests in former Bitcoin miners including Core Scientific (CORZ). Billionaire investment signals positive sentiment that may moderately lift CORZ market performance.

27 Aug

3

Core Scientific (CORZ) could be 53% undervalued if its growth story materializes. A valuation opinion on potential undervaluation may moderately shift investor sentiment toward CORZ.

26 Aug

4

Core Scientific spent $444 million on additional power capacity as part of its ongoing infrastructure expansion. The large-scale power investment marks a major strategic move that can significantly expand operational capacity and alter the company's growth trajectory.

16 Aug

4

Core Scientific stock jumped 90% as Bitcoin fell 44%, with the company's pivot into AI infrastructure cited as the driver behind miner outperformance. Core Scientific's AI pivot represents a major strategic shift that can materially change its revenue base and valuation trajectory beyond Bitcoin mining.

14 Aug

4

Core Scientific closes $444 million deal for Polaris and targets 1.5 GW Muskogee campus. Major acquisition and large-scale campus expansion will significantly boost capacity and market position.

10 Aug

3

Core Scientific completed early delivery of its Cipher Digital project, but further growth depends on Texas developments. Early Cipher Digital delivery offers operational gains while Texas dependency caps near-term expansion for Core Scientific.

9 Aug

4

Core Scientific shareholders rejected a $9 billion sale. The AMD deal now tests whether that rejection strengthens the company's independent trajectory. Rejected buyout plus AMD partnership marks a major strategic pivot with clear potential to reshape Core Scientific's market position.

3 Aug

5

AMD secures 2.5 gigawatts from Core Scientific for AI data centers. 2.5 gigawatts AI deal with AMD transforms Core Scientific revenue base and competitive position.

31 Jul

3

Core Scientific stock receives fair value upgrade tied to AMD deal while analysts remain split on outlook. AMD deal triggers valuation adjustment yet split analyst views cap overall trajectory change.

30 Jul

4

Core Scientific, Inc. (CORZ) enters landmark AI power agreement, sending strong positive signal for AMD stock performance. Landmark AI power agreement drives major strategic expansion for Core Scientific in AI infrastructure.

4

Core Scientific enters a new deal with AMD that boosts AMD stock performance and supports Core Scientific infrastructure expansion. Deal with AMD upgrades Core Scientific technology base and accelerates its growth trajectory.

3

KBW upgraded Core Scientific after AMD leases raised contracted value, targeting 35% upside. KBW upgrade on AMD leases signals higher contracted value that may lift near-term sentiment and valuation.

29 Jul

5

Core Scientific forms a $14 billion AI partnership with AMD that serves as a turning point for the company. The $14 billion AI partnership with AMD transforms Core Scientific's market position and future trajectory.

4

AMD's partnership with Core Scientific exceeds the reported headline value, expanding the scope of their collaboration in data center and computing infrastructure. Larger-than-expected AMD deal directly boosts Core Scientific revenue visibility and competitive positioning in high-performance computing.

4

AMD and Core Scientific partner to pair AI chips with up to 2.5 gigawatts of power capacity for expanded operations. Partnership deploys up to 2.5 gigawatts for AI chips and expands Core Scientific infrastructure at scale.

4

Needham raises Core Scientific price target to $35 after AMD lease agreement. Target hike after AMD lease points to major expansion in high-value computing contracts.

4

Core Scientific (CORZ) stock trades above fair value after landing a major AI deal. Major AI deal drives significant revenue upside and business shift into data centers.

3

AMD stock fell 5.7% as AI sector weakness overshadowed a 2.5-gigawatt deal involving Core Scientific. Major 2.5-gigawatt AMD deal offers CORZ expansion upside yet AI rout creates offsetting negative market pressure.

3

Wedbush flags that Core Scientific's AMD deal includes conditions that may restrict benefits and add costs, tempering expected gains from the partnership. AMD deal caveats could moderately affect CORZ revenue trajectory and investor sentiment without reshaping core operations.

3

CORZ shares rose after multiple price target hikes. Wall Street analysts view the AMD deal as a large quality lease. Analyst price target increases tied to the AMD lease may lift near-term investor sentiment and valuation without altering core operations.

28 Jul

5

Core Scientific has signed a $14 billion deal with AMD and an undisclosed neocloud provider. The $14 billion AMD deal will fundamentally reshape Core Scientific's competitive position and growth trajectory.

5

Core Scientific reports Q2 earnings and lands $14B AMD deal. Galaxy Digital advances 74 MW site. Meta and Blackrock commit $14B to data center. $14B AMD deal marks transformative expansion for Core Scientific operations and positioning.

4

Core Scientific Inc (CORZ) Q2 2026 earnings call highlighted strategic partnerships and robust performance metrics. Strategic partnerships from earnings call signal major trajectory shifts for Core Scientific operations and market position.

4

AMD partners with Core Scientific on AI infrastructure, signaling intensified competition in the AI sector. AMD partnership marks major strategic expansion for Core Scientific in AI infrastructure.

4

Core Scientific shares fell 7.4% after reporting a large Q2 loss alongside an AMD AI deal, raising questions on whether the company's growth outlook remains intact. Q2 loss and AMD AI partnership substantially shift Core Scientific financial results and strategic positioning.

stockrow.com/CORZ · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com